A bill to require the Secretary of Health and Human Services to make determinations of the exclusivity periods for which licensed biological products are eligible.
This document is hosted on the original agency website.
Open document on the source website →
Some city and county websites restrict direct document access. If the document does not open, it may need to be viewed from that agency's own website.
Searchable Text
No searchable text available for this document.
